AFYREN SAS provides biobased products to replace petroleum-based molecules in France. It offers acetic, propionic, butyric and isobutyric, valeric and isovaleric, and caproic acids. The company's products are used in the flavors and fragrances, lubricants and functional fluids, feed, food, life sciences, and materials science markets. The company was founded in 2012 and is headquartered in Clermont-Ferrand, France.…
AFYREN and MINASOLVE Announce Partnership Agreement to Jointly Develop Key Bio-Based Molecules for the Fragrances Industry at Industrial Scale
AFYREN SAS (EPA: ALAFY) is listed on Euronext Paris, where its shares trade in EUR. It belongs to the Specialty Chemicals industry, part of the Basic Materials sector, and reports about 149 employees.
The shares were at 2.155 EUR on 20 November 2026, up 0.7% over 52 weeks. Its 52-week range is 2.065 EUR to 3.235 EUR: the price is 33.4% below the high and 4.4% above the low.
Its market capitalisation is 83.31M EUR.
AFYREN SAS reports return on equity of -23.1% and revenue up 18.7% year over year.
Its debt exceeds its cash by 23.53M EUR, a debt-to-equity ratio of 0.04. Its Piotroski F-score is 3 out of 9, a weak reading of its financial health. 3 analysts cover the stock; their mean price target of 4.433 EUR is 105.7% above the current price. The next earnings report is expected on 31 March 2027.